watch
Roche Holding AG

Roche Holding AG

Sector: Pharmaceutical Preparations Region: Switzerland


: | XETRA: RHO5 | OTC Markets: RHHVF | SIX Swiss Exchange: ROG | OTC Markets: RHHBY | OTC Markets: RHHBF | SIX Swiss Exchange: RO


Similar to: Pernix Therapeutics Holdings, Inc., Transgene SA, Skystar Bio-Pharmaceutical Co.

Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. It is also a leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Twenty-four medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy. Roche employs over 85,000 people worldwide. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Executives

Dr. Severin Schwan, Chief Executive Officer Roche Group
Nationality: Austrian Year of Birth: 1967 Studies: Economics at University of Innsbruck, University of York and University of Oxford Law at University of Innsbruck Doctorate in Law at University of Innsbruck Professional Career: 1993 - 1995: Trainee at Corporate Finance, Roche Basel 1995 - 1998: Head Finance & Administration, Roche Brussels 1998 - 2000: Head Finance & Informatics at Roche Grenzach, Germany and Member of the Executive Board of Roche Deutschland Holding GmbH 2000 - 2004: Head Global Finance & Services, Roche Diagnostics, Basel 2004 - 2006: Head Region Asia Pacific, Roche Diagnostics Singapore 2006 - 2008: Chief Executive Officer Division Roche Diagnostics since 2008: Chief Executive Officer Roche Group
Daniel O'Day, Chief Operating Officer Pharmaceuticals
Professional Career: 1987-95 Roche Pharma, USA Various commercial/sales roles 1995 Roche Pharma, USA Director Human Resources 1996 Roche Pharma, USA Director Product Marketing 1998 Roche Pharma HQ, Switzerland Head Business Unit, Arthritis and Respiratory 1999 Roche Pharma HQ, Switzerland Lifecycle Leader Tamiflu 2001 Roche Pharma, Japan Head Corporate Planning, Tokyo 2003 Roche Pharma, Denmark General Manager 2006 Roche Molecular Diagnostics (RMD), Pleasanton, USA President & CEO 2010 Roche Diagnostics Division, Chief Operating Officer and Member of the Roche Corporate Executive Committee 2012 Roche Pharmaceuticals Division, COO and Member of the Roche Corporate Executive Committee
Roland Diggelmann, Chief Operating Officer Diagnostics
Professional Career: 1995 AlloPro AG, Switzerland Manager Strategic Planning, 1997 Sulzer Orthopedics Ltd, Switzerland Director Strategic Planning & Marketing 1999 Sulzer Orthopedics Ltd, Switzerland Executive VP Strategic Planning & Marketing 2001 Sulzer Orthopedics Ltd, Switzerland Executive VP Sales Asia Pacific 2002 Sulzer Medica/Centerpulse Ltd, Switzerland Executive VP Sales Europe and Asia Pacific 2004 Zimmer GmbH, Japan Managing Director 2006 Zimmer GmbH, Switzerland Senior VP Sales / Distribution EMEA and Managing Director 2008 Roche Diagnostics Asia Pacific, Singapore Head Region Asia Pacific 2012 Roche Diagnostics Division, Chief Operating Officer and Member of the Roche Corporate Executive Committee
Dr. Alan Hippe, Chief Financial and IT Officer
Professional Career: 1993-1996 University of Mainz, Research Assistant University of Mannheim, Teaching Assistant 1996 AVECO Holding AG, Head of group controlling and IT systems 1998 Fraport AG, Senior vice president controlling, Finance and accounting 2002 Continental AG, Chief financial officer, Member of the executive board 2005 Continental Tire of North America, President 2008 Continental group, Vice chairman of the executive board Head of the global car tire business Head of Conti Rubber 2009 ThyssenKrupp AG, Member of the Executive Board ThyssenKrupp Business Services
Silvia Ayyoubi, Head of Human Resources
Professional Career: 1974 Swiss Ministry of Foreign Affairs Switzerland, Sweden, Egypt, Jordan 1986 Effifreight, Basel 1987 F. Hoffmann-La Roche Ltd, Basel Public Relations Assistant, Pharma Communications 1989 Public Relations and Issue Manager 1991 Corporate Human Resources, Head of Executive Resource Planning Pharma 1996 Corporate Human Resources, Head of Executive Development 2001 Diagnostics Division, Head of Global Human Resources 2008 Head of Human Resources, Member of the Corporate Executive Committee
Dr. Gottlieb A. Keller, General Counsel
Professional Career: 1984 Corporate Law Department of the Roche Group 1989 Head of Business Development and Pharma Marketing Services Roche Grenzach, Germany 1992 Assistant to the Chairman of the Board of Directors of Roche Holding Ltd 1996 Head of Human Resources Hoffmann-La Roche Ltd, Germany 1998 Speaker of the Management Board, Hoffmann-La Roche Ltd, Germany 1999 Chairman of the Executive Board of Roche Deutschland Holding GmbH 1999 Secretary to the Board of Directors of Roche Holding Ltd and Corporate Compliance Officer of the Roche Group 2003 Member of the Corporate Executive Committee of the Roche Group Head of Corporate Human Resources and Pharma Site Management Basel and Kaiseraugst 2004 Head of Corporate Services and Human Resources 2008 General Counsel

News & Analysis

You may also be interested in: